Vascular Impact of Cancer Therapies: The Case of BTK (Bruton Tyrosine Kinase) Inhibitors

Matthew R. Fleming, Ling Xiao, Klarissa D. Jackson, Joshua A. Beckman, Ana Barac, Javid J. Moslehi

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Fingerprint

Dive into the research topics of 'Vascular Impact of Cancer Therapies: The Case of BTK (Bruton Tyrosine Kinase) Inhibitors'. Together they form a unique fingerprint.

Medicine & Life Sciences